Back to results
US 2021/0259989 A1Published application
Transdermal delivery of cannabidiol
AssigneePike Therapeutics, Inc., 1219014 B.C. Ltd
InventorsFotios M. Plakogiannis, Tamanna Lather, Nisarg Modi, Marina Borovinskaya
Life of this patent
Estimating the term…
Abstract
Provided is a transdermal drug delivery system comprising cannabidiol, or a cannabidiol salt alone or in combinations thereof. Transdermal delivery can provide a drug plasma concentration at predetermined rate for a predetermined period of time with a simplified therapeutic regimen by decreasing dosing frequency for the treatment and/or prevention of pain and/or inflammation.
Claims23
A transdermal and/or topical pharmaceutical composition comprising:
- about 0.1% to about 20% of an active agent selected from the group consisting of synthetic cannabidiol, natural cannabidiol, and combinations thereof;
- about 35% to about 99% of at least one adhesive and/or polymer;
- optionally about 0.1% to about 30% of at least one penetration enhancer;
- optionally about 0.1% to about 40% of a gelling agent.
1 more element
Dependencies are inferred from the claim text.